Linked Life Data

16507946

Source:http://linkedlifedata.com/resource/pubmed/id/16507946

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-3-1
pubmed:abstractText
Screening for the risk of fetal aneuploidy can be effectively performed in either the first or second trimester. When obtained independently, the interpretation of those data is straightforward. However, the effectiveness of screening can be enhanced by combining studies performed in each trimester in a variety of ways. In this commentary we will define and discuss both the advantages and disadvantages of using integrated, stepwise, sequential or contingency screening for risk assessment of fetal aneuploidy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1873-233X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
107
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
715-8
pubmed:dateRevised
2009-10-26
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Aneuploidy screening: what test should I use?
pubmed:affiliation
Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10128, USA. rb2212@columbia.edu
pubmed:publicationType
Journal Article